| Code | 6932D | ||||||||||
| MA number | 29/0070/21-S | ||||||||||
| Product Form: | sol iru 1x0,200 ml/7,5 mg (striek.inj.skl.napl.s ihlou) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 14.04.2021 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_FOXIEMO_05.2023.pdf
|
| PIL: |
PIL_FOXIEMO_05.2023.pdf
|
| Safety feature | Yes |
| Data update: | 02.04.2024 |
